Evidence map›Paper›PMID 37228611›Full record

ArticleFrontiers in immunology2023

Substance P analogs devoid of key residues fail to activate human mast cells

Shammy Raj, Stepan Hlushak, Narcy Arizmendi, Andriy Kovalenko, Marianna Kulka

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Shammy RajNanotechnology Research Centre, National Research Council Canada, Edmonton, AB, Canada.
Stepan HlushakDepartment of Mechanical Engineering, University of Alberta, Edmonton, AB, Canada.
Narcy ArizmendiNanotechnology Research Centre, National Research Council Canada, Edmonton, AB, Canada.
Andriy KovalenkoNanotechnology Research Centre, National Research Council Canada, Edmonton, AB, Canada.
Marianna KulkaNanotechnology Research Centre, National Research Council Canada, Edmonton, AB, Canada.
National Institute for Nanotechnology · CANational Research Council Canada · CAUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells play an important role in disease pathogenesis by secreting immunomodulatory molecules. Mast cells are primarily activated by the crosslinking of their high affinity IgE receptors (FcεRI) by antigen bound immunoglobulin (Ig)E antibody complexes. However, mast cells can also be activated by the mas related G protein-coupled receptor X2 (MRGPRX2), in response to a range of cationic secretagogues, such as substance P (SP), which is associated with pseudo-allergic reactions. We have previously reported that the

Indexed as

Mast CellsSubstance PAnimalsCongenital Disorders of GlycosylationHumansImmunoglobulin ELigandsMiceNerve Tissue ProteinsReceptors, G-Protein-CoupledReceptors, NeuropeptideSecretagoguesImmunoglobulin ELigandsMRGPRX2 protein, humanNerve Tissue ProteinsReceptors, G-Protein-CoupledReceptors, NeuropeptideSecretagoguesSubstance Pamino acid residuesligand-receptor interactionsmast cellsMRGPRX2substance P

Identifiers

PMID37228611
PMCPMC10203606
OpenAlexW4375950743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.